Reliq Health Technologies, Inc. To Participate In The Lytham...| MENAFN.COM

Friday, 03 February 2023 03:16 GMT

Reliq Health Technologies, Inc. To Participate In The Lytham Partners Investor Select Conference


(MENAFN- GlobeNewsWire - Nasdaq)

HAMILTON, Ontario, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“ Reliq ” or the“ Company ”), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it will be participating in the Lytham Partners Investor Select Conference taking place virtually on January 31, 2023. During the event, the company will be participating in a webcasted fireside chat discussion and conducting 1x1 virtual investor meetings.

Company Webcast
The Company's webcast presentation will be available for viewing at 9:00am ET on Tuesday, January 31, 2023 on the Company's website at or .The webcast will also be available for replay following the event.

1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a 1x1 meeting with management, please contact Lytham Partners at or register at .

Reliq Health
Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq's powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN: A2AJTB.

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

MENAFN25012023004107003653ID1105475840


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.